Titlebook: Cardiovascular Genomics; Mohan K. Rai,Julian F. R. Paton,Michael J. Katovic Book 2005 Humana Press 2005 Angiotensin II.cardiovascular.gene

典型

Book 2005both health and disease. The authors focus on all components of the system, including blood vessels, heart, kidneys, and the brain, and cover disease states ranging from vascular and cardiac dysfunction to stroke and hypertension. The methods described for identifying the genes that cause susceptibi

浮雕宝石

完整

Carcinoma

CODA

2196-8969 d ground-breaking, Cardiovascular Genomics offers an unprecedented examination of both the cutting-edge scientific approaches now possible and the results obtained from them in the new science of cardiovascular genomics.978-1-61737-542-2978-1-59259-883-0Series ISSN 2196-8969 Series E-ISSN 2196-8977

obligation

胆小鬼

花费

23-90 - 23-152: CBr4 - C6H5FN.BrH,ion-competent endothelial precursor cells from adult bone marrow provides a novel opportunity for repair of the failing heart using autologous cell transplantation. In this chapter we will focus on the latest advances in the field of gene- and cell-based therapies for treatment of heart failure, and their clinical applications.

Radiation

Local Production of Angiotensinogendetail a strategy using well-characterized cell-specific promoters to specifically target the . gene to defined cells and tissues. The development and characterization of these models has helped uncover the role and significance of local production of AGT in several tissues.

palette

Genetic Polymorphisms and Response to HMG-CoA Reductase Inhibitors is that in the future, a subject’s genotype may determine whether he/she will be treated with statins or not. Determining the genotype will not deny therapy to a subject, but will help in the decision as to which therapy suits the patient best.